Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension in pregnancy.

Anthony R Gregg1

  • 1Department of Obstetrics and Gynecology, Department of Molecular and Human Genetics, Baylor College of Medicine, 6550 Fannin Suite, 901A, Houston, TX 77030, USA. agregg@bcm.tmc.edu

Obstetrics and Gynecology Clinics of North America
|June 18, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Birth After Uterus Transplant.

JAMA·2026
Same author

Novel Unbalanced Translocation t(3;13)(q29;q34) in an Infant With Hydrocephalus.

Birth defects research·2025
Same author

Uterus Transplant-Reply.

JAMA·2024
Same author

Leveraging diverse genomic data to guide equitable carrier screening: Insights from gnomAD v.4.1.0.

American journal of human genetics·2024
Same author

Uterus Transplant in Women With Absolute Uterine-Factor Infertility.

JAMA·2024
Same author

Laboratory testing for preconception/prenatal carrier screening: A technical standard of the American College of Medical Genetics and Genomics (ACMG).

Genetics in medicine : official journal of the American College of Medical Genetics·2024

Hypertensive disorders in pregnancy, including pre-eclampsia, are best managed with delivery around 37 weeks gestation. Management before this time requires careful consideration due to limited evidence.

Area of Science:

  • Obstetrics and Gynecology
  • Maternal-Fetal Medicine
  • Hypertensive Disorders of Pregnancy

Background:

  • Hypertensive diseases of pregnancy encompass several conditions with evolving definitions.
  • Accurate diagnosis and timely management are crucial for maternal and fetal outcomes.

Purpose of the Study:

  • To review current guidelines and evidence for managing hypertensive disorders in pregnancy.
  • To provide clarity on optimal timing for delivery based on gestational age and condition severity.

Main Methods:

  • Literature review of professional organization guidelines.
  • Analysis of studies on pregnancy hypertension management.
  • Synthesis of evidence regarding delivery timing.

Main Results:

Related Experiment Videos

  • Mild pre-eclampsia management: delivery at or beyond 37 weeks' gestation.
  • Severe pre-eclampsia management: delivery at or beyond 34 weeks' gestation.
  • Chronic hypertension, gestational hypertension, and superimposed pre-eclampsia generally warrant delivery by 37 weeks.

Conclusions:

  • Delivery timing is a key factor in managing hypertensive disorders of pregnancy.
  • Evidence supports delivery around 37 weeks for most hypertensive conditions.
  • Management before 37 weeks requires careful interpretation of limited data.